Not Yet Recruiting
The Efficacy and Safety of TAS-102(Suyuan) Combined With Bevacizumab as First-line Therapy in Patients With Advanced Colorectal Cancer
NCT06092242
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
- Locations
-
- The Second Affiliated Hospital of Shandong First Medical University Tai’an, Shandong, China